Pure Biologics Spólka Akcyjna (PUR.WA)

PLN 15.22

(-8.86%)

Total Assets Summary of Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna's latest annual total assets in 2023 was 22.73 Million PLN , down -31.12% from previous year.
Pure Biologics Spólka Akcyjna's latest quarterly total assets in 2024 Q2 was 11.42 Million PLN , down -41.88% from previous quarter.
Pure Biologics Spólka Akcyjna reported annual total assets of 33 Million PLN in 2022, down -30.05% from previous year.
Pure Biologics Spólka Akcyjna reported annual total assets of 47.19 Million PLN in 2021, up 149.13% from previous year.
Pure Biologics Spólka Akcyjna reported quarterly total assets of 19.65 Million PLN for 2024 Q1, down -13.58% from previous quarter.
Pure Biologics Spólka Akcyjna reported quarterly total assets of 22.73 Million PLN for 2023 Q4, down -65.11% from previous quarter.

Annual Total Assets Chart of Pure Biologics Spólka Akcyjna (2023 - 2016)

Historical Annual Total Assets of Pure Biologics Spólka Akcyjna (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	22.73 Million PLN	-31.12%
2022	33 Million PLN	-30.05%
2021	47.19 Million PLN	149.13%
2020	18.94 Million PLN	-13.05%
2019	21.78 Million PLN	231.17%
2018	6.57 Million PLN	395.97%
2017	1.32 Million PLN	39.35%
2016	951.82 Thousand PLN	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	11.42 Million PLN	-41.88%
2024 Q1	19.65 Million PLN	-13.58%
2023 Q4	22.73 Million PLN	-65.11%
2023 Q1	72.55 Million PLN	119.79%
2023 FY	22.73 Million PLN	-31.12%
2023 Q2	74.56 Million PLN	2.77%
2023 Q3	65.17 Million PLN	-12.58%
2022 Q4	33 Million PLN	9.08%
2022 Q3	30.26 Million PLN	-30.11%
2022 FY	33 Million PLN	-30.05%
2022 Q2	43.29 Million PLN	-12.21%
2022 Q1	49.31 Million PLN	4.5%
2021 Q2	61.28 Million PLN	-6.8%
2021 FY	47.19 Million PLN	149.13%
2021 Q4	47.19 Million PLN	-15.38%
2021 Q3	55.76 Million PLN	-9.01%
2021 Q1	65.76 Million PLN	247.18%
2020 Q4	18.94 Million PLN	0.78%
2020 FY	18.94 Million PLN	-13.05%
2020 Q3	18.79 Million PLN	-14.92%
2020 Q1	20.14 Million PLN	-7.54%
2020 Q2	22.09 Million PLN	9.67%
2019 Q2	16.4 Million PLN	75.66%
2019 FY	21.78 Million PLN	231.17%
2019 Q4	21.78 Million PLN	21.51%
2019 Q3	17.92 Million PLN	9.26%
2019 Q1	9.34 Million PLN	42.0%
2018 Q3	3.98 Million PLN	0.0%
2018 FY	6.57 Million PLN	395.97%
2018 Q1	- PLN	-100.0%
2018 Q4	6.57 Million PLN	64.89%
2017 FY	1.32 Million PLN	39.35%
2017 Q4	1.32 Million PLN	0.0%
2016 FY	951.82 Thousand PLN	0.0%

Peer Total Assets Comparison of Pure Biologics Spólka Akcyjna

Name	Total Assets	Total Assets Difference
Bioceltix S.A.	12.73 Million PLN	-78.543%
BIOTON S.A.	822.22 Million PLN	97.235%
Captor Therapeutics Spolka Akcyjna	97.29 Million PLN	76.63%
Mabion S.A.	208.25 Million PLN	89.082%
Molecure S.A.	168.57 Million PLN	86.512%
NanoGroup S.A.	8.63 Million PLN	-163.428%
Pharmena S.A.	24.13 Million PLN	5.777%
Poltreg S.A.	127.09 Million PLN	82.11%
Ryvu Therapeutics S.A.	403.2 Million PLN	94.361%
Synthaverse S.A.	265.9 Million PLN	91.449%
Urteste S.A.	29.59 Million PLN	23.177%